The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

CMS has published its final rule for Medicare Advantage and Part D in 2026, outlining a series of regulatory updates aimed at ...

The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey medications used to treat complex and chronic conditions, according to a new ...

with average prices consistently exceeding $1,500 per prescription, results show. "Despite this, adoption remained limited, as only 1 in 250 U.S. adults without diabetes used a GLP-1 [drug] in ...

It has expanded its offerings to include weight loss, focusing on prescription medications, including its own compounded semaglutide GLP-1 medication. In this article, we delve into Hers ...

GLP-1 drugs, originally for type 2 diabetes, are increasingly used for weight loss, but they can worsen eating disorders. Rapid weight loss from these drugs can reinforce harmful eating behaviors ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce inflammation and improve heart health. With such advantages, the demand ...